The Opportunity The Solution Target Market The Process The Team The Offering If you suffer from anaphylaxis, you can help prevent a reaction from occurring by avoiding the allergenic substance. However, avoidance is not enough. You cannot predict the movement of a flying insect, or always know the ingredients of your food. Surprises happen and sometimes you cannot avoid the harmful allergen. In this case you need to be prepared to treat the condition with epinephrine as soon as it arises.   There are three conditions which have created an opportunity for Medi-Life to capture a piece of this market. The industry has largely ignored consumers' need for a device that is easy to carry; less intimidating; and comfortable to use, focusing instead on military applications or markets where size and comfort are not as important to the consumer. The Medi-Card will be going through the shortest of all FDA applications, the 510K, which will take 45-120 days for clearance. The market is strong, healthy and growing. The self-injection device market is estimated at 4 billion dollars with a projected growth rate of 10-12%, while the target self injection epinephrine market is estimated at $215 million with a projected growth rate of 20-25%.

Product Opportunity Market Business Model Team Executive Summary 2006©. All rights reserved. Privacy Policy